Youcare Pharmaceutical Group Co., Ltd. (SHA:688658)
China · Delayed Price · Currency is CNY 12.28
+0.26 (2.16%)
Jul 31, 2026, 3:00 PM CST
SHA:688658 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -246.22 | -262.39 | 123.72 | 184.8 | 335.18 | 545.32 |
Depreciation & Amortization | 204.54 | 204.54 | 207.96 | 178.45 | 164.47 | 138.56 |
Other Amortization | 8.61 | 8.61 | 41.67 | 2.18 | 1.3 | 2.95 |
Loss (Gain) From Sale of Assets | -0.92 | -0.92 | 0.38 | -1.04 | -0.04 | -0.01 |
Asset Writedown & Restructuring Costs | 18.49 | 18.49 | 35.49 | 25.27 | 10.86 | 24.45 |
Loss (Gain) From Sale of Investments | -9.5 | -9.5 | -2.82 | 0.08 | -1.36 | -4.03 |
Provision & Write-off of Bad Debts | -3.62 | -3.62 | -6.3 | -14.36 | 21.45 | 20.64 |
Other Operating Activities | -18.37 | 34.36 | 49.48 | 53.23 | 51.52 | 23.43 |
Change in Accounts Receivable | 208.19 | 208.19 | 276.65 | 278.3 | -531.26 | -305.23 |
Change in Inventory | 266.71 | 266.71 | -59.15 | -30.61 | -158.22 | -26.08 |
Change in Accounts Payable | -156.76 | -156.76 | -218.9 | 148.97 | -46.91 | 98.77 |
Change in Other Net Operating Assets | - | - | - | -37.21 | 37.21 | -0.13 |
Operating Cash Flow | 303.72 | 340.29 | 438.24 | 785.49 | -121.17 | 515.24 |
Operating Cash Flow Growth | -18.61% | -22.35% | -44.21% | - | - | -26.15% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -103.54 | -135.08 | -358.6 | -497.48 | -547.96 | -200.49 |
Sale of Property, Plant & Equipment | 0.41 | 0.41 | 0.63 | 2.47 | 0.06 | 0.07 |
Cash Acquisitions | - | - | -3.01 | - | -10 | -6.83 |
Divestitures | - | - | - | 8.46 | - | 2.75 |
Investment in Securities | -622.67 | -349 | -175 | -15.5 | 1.36 | 3.67 |
Other Investing Activities | 19.18 | 14.01 | -9.78 | - | - | - |
Investing Cash Flow | -706.61 | -469.66 | -545.76 | -502.05 | -556.54 | -200.84 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | - | - | - | - | 9 |
Long-Term Debt Issued | - | 122.52 | 649.01 | 387.29 | 228.17 | - |
Total Debt Issued | 515.94 | 122.52 | 649.01 | 387.29 | 228.17 | 9 |
Short-Term Debt Repaid | - | - | - | - | - | -160.03 |
Long-Term Debt Repaid | - | -211.44 | -521.19 | -259.38 | -21.79 | -31.19 |
Total Debt Repaid | -682.96 | -211.44 | -521.19 | -259.38 | -21.79 | -191.22 |
Net Debt Issued (Repaid) | -167.02 | -88.91 | 127.82 | 127.91 | 206.37 | -182.22 |
Repurchase of Common Stock | - | - | -45.03 | -54.99 | - | - |
Common Dividends Paid | -23.33 | -23.24 | -111.25 | -505.12 | -307.98 | -204.94 |
Other Financing Activities | 21.08 | 0.1 | - | - | - | -21.11 |
Financing Cash Flow | -169.28 | -112.05 | -28.46 | -432.19 | -101.6 | -408.28 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.03 | 0.14 | 0.26 | 3.94 | 6.2 | -0.91 |
Net Cash Flow | -572.14 | -241.29 | -135.71 | -144.81 | -773.11 | -94.79 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 200.18 | 205.21 | 79.64 | 288.01 | -669.13 | 314.75 |
Free Cash Flow Growth | 318.75% | 157.67% | -72.35% | - | - | -44.87% |
Free Cash Flow Margin | 8.26% | 8.39% | 2.11% | 6.86% | -14.73% | 6.34% |
Free Cash Flow Per Share | 0.44 | 0.46 | 0.18 | 0.64 | -1.48 | 0.70 |
Levered Free Cash Flow | 261.3 | 231.47 | -138.08 | 166.18 | -823.25 | 116.5 |
Unlevered Free Cash Flow | 273.94 | 245.01 | -124.09 | 174.44 | -820.32 | 118.67 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 179.45 | 187.91 | 367.5 | 358.13 | 421.72 | 512.49 |
Change in Working Capital | 350.71 | 350.71 | -11.34 | 356.88 | -704.55 | -236.07 |